Which new countries are driving India's pharmaceutical export growth?

Brazil and Nigeria are emerging as key export destinations for Indian pharmaceutical firms.

What was the total value of India's pharmaceutical exports in April-November FY26?

India's pharmaceutical exports reached $20.48 billion during the April-November FY26 period.

Why are Brazil and Nigeria important for Indian pharma exports?

These markets show rising healthcare access, expanding public procurement, and growing reliance on Indian generics.

Home / Business and Economy / India Pharma Exports Surge: Brazil & Nigeria Lead Growth

India Pharma Exports Surge: Brazil & Nigeria Lead Growth

18 Jan

•

Summary

Brazil and Nigeria are now key export destinations for Indian pharmaceuticals.
Pharmaceutical exports rose by 6.5% to $20.48 billion in April-November FY26.
India's pharma exports show growing reliance on generics in emerging economies.

India Pharma Exports Surge: Brazil & Nigeria Lead Growth

India's pharmaceutical exports demonstrated robust growth, reaching $20.48 billion between April and November of FY26. This represents a 6.5% increase, driven significantly by emerging markets like Brazil and Nigeria, which are becoming key destinations for Indian drug manufacturers.

Nigeria alone contributed over 14% to the total export growth, adding $179 million, while Brazil saw nearly $100 million in increased exports. This trend underscores the rising demand for Indian generics, fueled by expanding healthcare access and public procurement in these high-growth regions.

While the United States continues to be the largest market, accounting for over 31% of exports, the overall growth profile reveals a broadening demand across diverse geographies, including steady increases from countries like France, the Netherlands, Canada, Germany, and South Africa. This balanced export architecture strengthens India's position as a reliable global pharmaceutical supplier.